2026年9月25日星期五
M
Rekod Semesta
Berita Pantas Global
Talent shortage emerges as tech's biggest bottleneck in AI expansion boom— 日经 Nikkei AsiaJapan's JFE Engineering, startups bet on Philippine renewable energy— 日经 Nikkei AsiaTaiwan's ruling DPP rethinks nuclear power opposition in AI era— 日经 Nikkei AsiaTokyo commercial land prices jump to 33-year high as remote work ebbs— 日经 Nikkei AsiaJapan Air Self-Defense Force confirms Global Hawk drone crash— 日经 Nikkei AsiaJapan trading house lobby chief urges stronger yen despite sector windfall— 日经 Nikkei AsiaUK eyes role in Vietnam infrastructure boom with $2.5bn metro financing— 日经 Nikkei AsiaAustralia's rising far-right leader raises alarm over China's EV influx— 日经 Nikkei AsiaTalent shortage emerges as tech's biggest bottleneck in AI expansion boom— 日经 Nikkei AsiaJapan's JFE Engineering, startups bet on Philippine renewable energy— 日经 Nikkei AsiaTaiwan's ruling DPP rethinks nuclear power opposition in AI era— 日经 Nikkei AsiaTokyo commercial land prices jump to 33-year high as remote work ebbs— 日经 Nikkei AsiaJapan Air Self-Defense Force confirms Global Hawk drone crash— 日经 Nikkei AsiaJapan trading house lobby chief urges stronger yen despite sector windfall— 日经 Nikkei AsiaUK eyes role in Vietnam infrastructure boom with $2.5bn metro financing— 日经 Nikkei AsiaAustralia's rising far-right leader raises alarm over China's EV influx— 日经 Nikkei Asia

Nicotine pharmacokinetics and abuse liability of commercially available tobacco products: an open-label, randomized, controlled study

Sumber Nature 医学研究8 hari lalu
Ringkasan kandungan

Nicotine pharmacokinetics and abuse liability of commercially available tobacco products: an open-label, randomized, controlled study

Laman ini hanya menyediakan indeks tajuk dan ringkasan, kandungan penuh dan hak cipta adalah milik pihak penerbit asal, sila klik pautan asal untuk membaca.

Pergi ke artikel asal
Saluran berkaitan
Kesihatan
Kawasan berkaitan
Perspektif global
Bahasa teks asal
English
Nombor entri
health-fbb71fa9

Comments 0 comments

No comments yet. Be the first.

Nicotine pharmacokinetics and abuse liability of commercially available tobacco products: an open-label, randomized, controlled study · Rekod Semesta